Furthermore, despite a slight trend, no significant reduction in intratumoral CD4 T and NK cells, as well as no differences in the frequency and phenotype of myeloid cells, were detected (Fig. 1c and Supplementary Fig. 1f, g ).
← all excerpts
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.
1
—
—